AU1877000A - Process for the preparation of an acetate salt of paroxetine or paroxetine analogues - Google Patents

Process for the preparation of an acetate salt of paroxetine or paroxetine analogues

Info

Publication number
AU1877000A
AU1877000A AU18770/00A AU1877000A AU1877000A AU 1877000 A AU1877000 A AU 1877000A AU 18770/00 A AU18770/00 A AU 18770/00A AU 1877000 A AU1877000 A AU 1877000A AU 1877000 A AU1877000 A AU 1877000A
Authority
AU
Australia
Prior art keywords
paroxetine
analogues
preparation
acetate salt
acetate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU18770/00A
Inventor
Andrew Simon Craig
David Alan Jones
John Man
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU1877000A publication Critical patent/AU1877000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU18770/00A 1998-12-29 1999-12-22 Process for the preparation of an acetate salt of paroxetine or paroxetine analogues Abandoned AU1877000A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9828780 1998-12-29
GBGB9828780.8A GB9828780D0 (en) 1998-12-29 1998-12-29 Novel process
PCT/GB1999/004367 WO2000039122A1 (en) 1998-12-29 1999-12-22 Process for the preparation of an acetate salt of paroxetine or paroxetine analogues

Publications (1)

Publication Number Publication Date
AU1877000A true AU1877000A (en) 2000-07-31

Family

ID=10845133

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18770/00A Abandoned AU1877000A (en) 1998-12-29 1999-12-22 Process for the preparation of an acetate salt of paroxetine or paroxetine analogues

Country Status (5)

Country Link
EP (1) EP1140911A1 (en)
JP (1) JP2002533458A (en)
AU (1) AU1877000A (en)
GB (1) GB9828780D0 (en)
WO (1) WO2000039122A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130172562A1 (en) * 2010-06-17 2013-07-04 Dr. Reddy's Laboratories, Inc. Process for the preparation of a single enantiomer of 3-aminopiperidine dihydrochloride

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
HU221921B1 (en) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzyl-piperidine or tetrahydro-pyridine derivatives and processes for producing them
DK0994872T3 (en) * 1997-06-10 2001-05-28 Synthon Bv 4-phenylpiperidine compounds

Also Published As

Publication number Publication date
JP2002533458A (en) 2002-10-08
GB9828780D0 (en) 1999-02-17
EP1140911A1 (en) 2001-10-10
WO2000039122A1 (en) 2000-07-06

Similar Documents

Publication Publication Date Title
AU6107399A (en) Process for the preparation of ethyl acetate
AU7902400A (en) Method for the preparation of 5-carboxyphthalide
AU3422399A (en) Method for the preparation of modified cellulose ethers
AU2002300593A1 (en) Process for the preparation of thiazolidinedione derivatives
AU6123099A (en) Process for the preparation of amine derivatives
AU5762099A (en) The preparation of (n)-substituted-hydroxycycloalkylamine derivatives
HUP9900344A3 (en) Process for the preparation of an optically active indoline-2-carboxylic acid or derivative thereof
AU5536599A (en) Process for the preparation of neotame
AU5737498A (en) Method for the preparation of alpha-bromo-lactam derivatives
AU4659199A (en) Process for the preparation of urea
AU2376001A (en) Method for the manufacture of olefins
AU6292998A (en) Process for the preparation of thiazole derivatives
AU5831500A (en) Process for the preparation of polyols
AU1037901A (en) Process for the preparation of paroxetine
AU6484599A (en) An improved process for the preparation of 7-azaindolyl-3-carboxylic acid
AU2943400A (en) Process for the preparation of alpha-aminoketone derivatives
AU3818900A (en) Process for the preparation of substituted piperidines
AU7958000A (en) Process for the preparation of oxyiminoalkanoic acid derivatives
AU2829700A (en) Processes for the preparation of alpha-aminoketones
AU1877000A (en) Process for the preparation of an acetate salt of paroxetine or paroxetine analogues
AU1876700A (en) Process for the preparation of an acetate salt of paroxetine or paroxetine analogues
AU5621399A (en) Method for measuring the movements of the heart
AU1130901A (en) Method for the preparation of 5-carboxyphthalide
AU1877300A (en) Process for the preparation of an acetate salt of paroxetine or paroxetine analogues
AU5779998A (en) Process for the preparation of cyanoarylmethylamine

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase